Scott Jones
Corporate Officer/Principal bei EYEPOINT PHARMACEUTICALS, INC.
Vermögen: 725 843 $ am 30.04.2024
Profil
Scott Jones is currently the Chief Commercial Officer & Senior Vice President at EyePoint Pharmaceuticals, Inc. He previously worked as the Executive Director-Health Policy at Novartis Pharmaceuticals Corp.
from 2006 to 2009, as the Executive Director & Head-Market Access at Novartis Ophthalmics, Inc. from 2004 to 2006, as the President at QLT Ophthalmics, Inc. from 2009 to 2013, and as the Chief Commercial Officer & VP-Business Development at Notal Vision, Inc. from 2013 to 2019.
Mr. Jones received his undergraduate and graduate degrees from the University of Florida.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 09.02.2024 | 44 916 ( 0,09% ) | 725 843 $ | 30.04.2024 |
Aktive Positionen von Scott Jones
| Unternehmen | Position | Beginn |
|---|---|---|
| EYEPOINT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 10.06.2019 |
Ehemalige bekannte Positionen von Scott Jones
| Unternehmen | Position | Ende |
|---|---|---|
Notal Vision, Inc.
 Notal Vision, Inc. Medical SpecialtiesHealth Technology Part of Notal Vision Ltd., Notal Vision, Inc. develops ophthalmic diagnostic devices. The private company is based in Manassas, VA. The company was founded by Barak Azmon. The CEO is Kester Nahen. | Corporate Officer/Principal | 01.06.2019 |
| QLT Ophthalmics, Inc. | Präsident | 01.01.2013 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01.01.2009 |
Novartis Ophthalmics, Inc.
 Novartis Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Ophthalmics, Inc. was a producer of pharmaceuticals, eye care and generic drugs. The company was headquartered in Duluth, GA. | Direktor/Vorstandsmitglied | 01.01.2006 |
Ausbildung von Scott Jones
| University of Florida | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| EYEPOINT PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Notal Vision, Inc.
Notal Vision, Inc. Medical SpecialtiesHealth Technology Part of Notal Vision Ltd., Notal Vision, Inc. develops ophthalmic diagnostic devices. The private company is based in Manassas, VA. The company was founded by Barak Azmon. The CEO is Kester Nahen. | Health Technology |
| QLT Ophthalmics, Inc. | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Novartis Ophthalmics, Inc.
Novartis Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Ophthalmics, Inc. was a producer of pharmaceuticals, eye care and generic drugs. The company was headquartered in Duluth, GA. | Health Technology |
